[Vaccine prophylaxis and chemoprophylaxis of cerebrospinal meningitis].
The Author points up a review on the argument accordingly to the most recent literatur. Particularly are treated the status of meningococcal vaccines anti-A, C and Y groups (their preparations and trends in Field-trials), and the status of proteic vaccines anti-B. In the second part the most important substances in chemio-antibiotic prophylaxis are considered (rifampin, minocyclin, sulphadiazine, TMP, etc.) accordingly to their efficacy, safety and side-effects. The status of the perspectives on the control of the desease is discussed at the end.
D000328:Adult; D000367:Age Factors; D000900:Anti-Bacterial Agents / Q000008:administration & dosage / Q000494:pharmacology / Q000627:therapeutic use*; D000942:Antigens, Bacterial / Q000032:analysis; D001428:Bacterial Vaccines / Q000032:analysis; D002648:Child; D002675:Child, Preschool; D006801:Humans; D007223:Infant; D008585:Meningitis, Meningococcal / Q000517:prevention & control*; D009345:Neisseria meningitidis / Q000187:drug effects; D011135:Polysaccharides, Bacterial / Q000032:analysis; D014611:Vaccination
D000900:Anti-Bacterial Agents; D000942:Antigens, Bacterial; D001428:Bacterial Vaccines; D011135:Polysaccharides, Bacterial
Vaccino e chemio-profilassi della meningite C. S.